The 7-transmembrane or G protein-coupled receptors relay signals from hormones and sensory stimuli to multiple signaling systems at the intracellular face of the plasma membrane including heterotrimeric G proteins, ERK1/2, and arrestins. It is an emerging concept that 7-transmembrane receptors form oligomers; however, it is not well understood which roles oligomerization plays in receptor activation of different signaling systems. To begin to address this question, we used the angiotensin II type 1 (AT 1 ) receptor, a key regulator of blood pressure and fluid homeostasis that in specific context has been described to activate ERKs without activating G proteins. By using bioluminescence resonance energy transfer, we demonstrate that AT 1 receptors exist as oligomers in transfected COS-7 cells. AT 1 oligomerization was both constitutive and receptor-specific as neither agonist, antagonist, nor co-expression with three other receptors affected the bioluminescence resonance energy transfer 2 signal. Furthermore, the oligomerization occurs early in biosynthesis before surface expression, because we could control AT 1 receptor export from the endoplasmic reticulum or Golgi by using regulated secretion/aggregation technology (RPD TM ). Co-expression studies of wild type AT 1 and AT 1 receptor mutants, defective in either ligand binding or G protein and ERK activation, yielded an interesting result. The mutant receptors specifically exerted a dominant negative effect on G␣ q activation, whereas ERK activation was preserved. These data suggest that distinctly active conformations of AT 1 oligomers can couple to each of these signaling systems and imply that oligomerization plays an active role in supporting these distinctly active conformations of AT 1 receptors.The 7-transmembrane (7TM) 1 or G protein-coupled receptors such as the angiotensin II type 1 (AT 1 ) receptor constitute the largest group of cell surface membrane receptors and mediate a vast array of biological effects in response to hormones, neurotransmitters, and sensory stimuli. The 7TM receptors activate or interact with numerous signaling proteins including heterotrimeric G proteins, arrestins, adaptor proteins, and extracellular signal-regulated kinases 1 and 2 (ERK1/2) at the intracellular face of the plasma membrane (1). Although 7TM receptors traditionally have been considered to work as monomeric entities, increasing evidence has shown that these receptors form both homo-and heterodimers or oligomers in vivo and in vitro. Whereas heterodimerization may provide a means to expand pharmacological diversity, the functional role of homodimerization is less well defined (2, 3). 7TM receptor heterodimerization has been shown to modify biological function, receptor trafficking, ligand binding properties, and signal transduction of several 7TM receptors (2, 3). The GABA B "receptor pair" provides an example of two different receptor subunits, the GABA B1 and GABA B2 , that both are necessary for receptor surface expression and function (4). The bradykinin B2 ...